Patient Preferences for Episodic Migraine Medications: A Discrete Choice Experiment of Self-Injectable Versus Oral Treatments Targeting Calcitonin Gene-Related Peptide Pathway

Patient Preferences for Episodic Migraine Medications: A Discrete Choice Experiment of Self-Injectable Versus Oral Treatments Targeting Calcitonin Gene-Related Peptide Pathway

Chiara Whichello,1 Lars Viktrup,2 Oralee J Varnado,2 Matthew Quaife,1 Myrto Trapali,1 Antje Tockhorn-Heidenreich3 1Evidera, London, UK; 2Eli Lilly and Company, Indianapolis, IN, USA; 3Eli Lilly and Company, Bracknell, UKCorrespondence: Antje Tockhorn-Heidenreich, Eli Lilly and Company Ltd, 8 Arlingt...

Full description

Saved in:
Bibliographic Details
Main Authors: Whichello C, Viktrup L, Varnado OJ, Quaife M, Trapali M, Tockhorn-Heidenreich A
Format: Article
Language:English
Published: Dove Medical Press 2025-03-01
Series:Patient Preference and Adherence
Subjects:
gepants
self-injectable treatment
treatment preferences
preventive treatment
united states
Online Access:https://www.dovepress.com/patient-preferences-for-episodic-migraine-medications-a-discrete-choic-peer-reviewed-fulltext-article-PPA
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/patient-preferences-for-episodic-migraine-medications-a-discrete-choic-peer-reviewed-fulltext-article-PPA

Similar Items